Lumasiran (sodium), CAS [[1834612-06-4]]

Product Overview

• Article Name: Lumasiran (sodium), CAS [[1834612-06-4]]
• Biozol Catalog Number: MCE-HY-132613
• Supplier Catalog Number: HY-132613
• Alternative Catalog Number: MCE-HY-132613-50MG,MCE-HY-132613-100MG,MCE-HY-132613-10MG,MCE-HY-132613-25MG,MCE-HY-132613-5MG,MCE-HY-132613-1MG
• Manufacturer: MedchemExpress
• Category: Biochemikalien

Product Description

Lumasiran sodium, an investigational RNA interference (RNAi) therapeutic agent, reduces hepatic oxalate production by targeting glycolate oxidase. Lumasiran sodium reduces urinary oxalate excretion, the cause of progressive kidney failure in primary hyperoxaluria type 1 (PH1) [1][2].

Product Properties

• Molecular Weight: 16340 (free acid)
• Purity: 99.21
• CAS Number: [1834612-06-4]
• Formula: C530H668F10N173Na44O320P43S6
• Target: Glycolate Oxidase,Small Interfering RNA (siRNA)

Application Notes

• Application Notes: MCE Product type: Oligonucleotides